Title : Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors.

Pub. Date : 2013 Nov

PMID : 24251790






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The best JAK2/JAK1 and PI3K inhibitor combination pair (ruxolitinib and GDC0941) reduces spleen weight in nude mice inoculated with Ba/F3 cells expressing TpoR and JAK2 V617F. ruxolitinib Janus kinase 2 Mus musculus
2 The best JAK2/JAK1 and PI3K inhibitor combination pair (ruxolitinib and GDC0941) reduces spleen weight in nude mice inoculated with Ba/F3 cells expressing TpoR and JAK2 V617F. ruxolitinib Janus kinase 2 Mus musculus